Crisalix News - IPRAS recommendation & successful Clinical Study
2012 is already in full swing at Crisalix, with e-Stetix version 5.1 released early January and many more new features and functionalities coming up shortly. In the meantime, I have some very exciting news to share with you.
IPRAS recommends Crisalix for the significant progress e-Stetix’s unique 3D simulation technology brings to the entire medical community and for its contribution to providing the highest level of patient care. SECPRE has endorsed e-Stetix for revolutionizing Plastic Surgery consultations and contributing to the Society’s objectives and values in providing high quality care for patients.
On a more technical note: identified as one of the most successful web solution companies within the healthcare industry, Crisalix becomes an IBM Global Entrepreneur.
Following a recent clinical study conducted in collaboration with renowned research centers in Switzerland, Crisalix has been granted a second round of financing by the Commission for Technology and Innovation.
Read on for more on these exciting news and stay tuned, there is a lot more to come.
Jaime Garcia, PhD
Chief Executive Officer
IPRAS recommends Crisalix
In acknowledgment of the benefits Crisalix’s unique 3D simulation technology brings to Plastic Surgery, specifically in answering every patient’s most common question, “how could I look after surgery”, it has recently received one of the highest forms of recognition in the industry: recommendation from IPRAS, one of the leading international federations for plastic surgery.
e-Stetix’s state of the art 3D simulation technology, exclusively available on the web requiring no additional hardware, assists Plastic Surgeons in gathering important information about the patient’s anatomy, highlighting individual characteristics and contributing to educate the patient about her own body. This helps the patient take better informed decisions about the upcoming surgery while taking into account both her expectations and her physical properties, resulting in higher post-surgery satisfaction levels.
This corresponds directly to the IPRAS’ objectives and values and leads to providing the highest level of patient care in the field of Plastic Surgery.
IPRAS also recommends e-Stetix for its unique solution making 3D consultation a new possible standard for any Plastic Surgeon around the world.
Crisalix endorsed by SECPRE
In the context of SECPRE’s goals and mission, in particular promoting the most appropriate measures for the development of Plastic, Reconstructive and Aesthetic Surgery, the Society has announced its endorsement of e-Stetix.
By providing patients with a precise visualization of post-operative results based on their own physical properties, e-Stetix’s 3D simulation technology coincides with SECPRE’s objectives and values in providing high quality care for Plastic Surgery patients and ensuring the highest level of professionalism.
In a world where 3D is starting to substitute all standard 2D visualization technology – similarly to what color did with black and white - and where web-based software has replaced the hardware business model in almost every field, SECPRE recognizes e-Stetix’s web-based 3D physical simulation solution as revolutionizing Plastic Surgery consultations.
Crisalix becomes an IBM Global Entrepreneur and ports e-Stetix into IBM’s Cloud
Since 2008 IBM has been working on their ‘Smarter Planet’ (http://www.ibm.com/smarterplanet) initiative with objective to make systems and industries around the world more efficient and intelligent in their way of thinking and functioning. As a pioneer in its field and as one of the most successful up and coming web solution companies in the healthcare industry, Crisalix became an IBM Global Entrepreneur in 2011.
IBM has a particular focus on the healthcare, and in particular on the patient and the care provided to them. Specifically, IBM’s ‘Smarter Planet’ initiative aims to transform powerful data of healthcare organizations to improve the quality of care and performance.During the course of the first quarter of 2012 Crisalix will be moving its technology to the IBM Cloud (http://www.ibm.com/cloud-computing/us/en/), benefiting from IBM’s high-level of support and experience in cloud computing technology and internet security. This will enable Crisalix to continue providing our clients with the utmost level of service and most advanced technology.
Crisalix awarded financing following successful Clinical Study
Following its recent clinical study conducted in Switzerland in collaboration with the Institute for Surgical Technology and Biomechanics at the University of Bern and the Department of Plastic and Reconstructive Surgery at the Inselspital also in Bern, Crisalix has been awarded a second round of funding from the Swiss Commission for Technology and Innovation (http://www.kti.admin.ch/).
This new project, with a financing value of 1.2 million CHF over 2 years, will contribute to Crisalix’s continuous development of its state of the art technology for plastic, reconstructive and aesthetic surgery.